Benjamin Dick

Benjamin Dick is currently the Scientific Lead in Structural Biology at Eli Lilly, where they apply their extensive expertise in biochemistry and medicinal bioinorganic chemistry. With a strong foundation in fragment-based and structure-based drug discovery, X-ray crystallography, and analytical method development, they previously held roles at Cambrex, University of California San Diego, and Bausch + Lomb. Benjamin earned a PhD in Chemistry and Biochemistry from the University of California San Diego and holds both a Master's and Bachelor's degree in Chemistry from the University of Rochester.